YTS109 cells

· China Immunotech (Beijing) Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YTS109 cells, covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases [Phase 1]